• Home /
  • Green Nanometals killing Cancer

Green Nanometals killing Cancer

Innovations to Commercialization
Artikelnummer: 978-981-9229-99-4
Einband: Fester Einband
Verfügbarkeit: Noch nicht erschienen, November 2026
CHF 215.00
decrease increase

This book explores the groundbreaking use of environmentally friendly nanometal technologies in the fight against cancer. This book explores innovative applications of nanometals that enhance diagnostic and therapeutic strategies. By integrating insights from materials science, chemistry, and medicine, it fosters interdisciplinary collaboration, highlighting cutting-edge research and advancements in nanotechnology for more effective and targeted cancer treatments. This book delves into the synthesis, applications, and future potential of green nanometals in improving cancer diagnosis and treatment, making it a vital resource for researchers, clinicians, and students in related fields. This book serves as an essential reference for researchers, healthcare professionals, and students, fostering interdisciplinary collaboration and innovation in cancer research. At outset, this book is not only timely but essential for advancing cancer diagnosis and treatment in a sustainable manner, ultimately contributing to better health outcomes and a healthier planet.


EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.

This book explores the groundbreaking use of environmentally friendly nanometal technologies in the fight against cancer. This book explores innovative applications of nanometals that enhance diagnostic and therapeutic strategies. By integrating insights from materials science, chemistry, and medicine, it fosters interdisciplinary collaboration, highlighting cutting-edge research and advancements in nanotechnology for more effective and targeted cancer treatments. This book delves into the synthesis, applications, and future potential of green nanometals in improving cancer diagnosis and treatment, making it a vital resource for researchers, clinicians, and students in related fields. This book serves as an essential reference for researchers, healthcare professionals, and students, fostering interdisciplinary collaboration and innovation in cancer research. At outset, this book is not only timely but essential for advancing cancer diagnosis and treatment in a sustainable manner, ultimately contributing to better health outcomes and a healthier planet.


EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.
Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer EN
EinbandFester Einband
Erscheinungsjahr2026
Seitenangabe628 S.
AusgabekennzeichenEnglisch
AbbildungenXXII, 606 p. 75 illus., 73 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen
MasseH23.5 cm x B15.5 cm
CoverlagSpringer (Imprint/Brand)
ReiheSmart Nanomaterials Technology
AutorFaiyazuddin, Md. (Hrsg.) / Sundaram, Gowri (Hrsg.) / Webster, Thomas J. (Hrsg.)

Alle Bände der Reihe "Smart Nanomaterials Technology"

Über den Autor Md. (Hrsg.) Faiyazuddin

Professor (Dr.) Md. Faiyazuddin is a distinguished academician with extensive experience working across the government, public, and private sectors who sought to leverage his sixteen-year background in pharmacy education, product development, research consultation, and social pharmacy outreach activities in academia and industry. Currently, he is employed as a senior professor at Al - Karim University, India, and holds visiting positions at prestigious universities in India and abroad. With more than a hundred studies, conferences, and review manuscripts, dozens of books and chapters, 15 accolades and awards, and various IPR have contributed greatly to the pharm fraternity of India. In addition to his daily job, Dr. Faiyazuddin has a keen interest in connecting researchers worldwide to practice safe drugs under the flagship of the International Pharmaceutical Forum (a community of more than 250 pharma stalwarts across the globe). Dr. Meghraj Vivekanand Suryawanshi (M.Pharm, PDCR, MBA, Ph.D.) is an Associate Professor and Training & Placement Coordinator at the Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences (SIPS), Nashik affiliated to SPPU, Pune. With over seven years of experience in pharmaceutical education and research, he holds degrees from SIPS, Lonavala, Pune, RCPIPER, Shirpur, and JNU, Jaipur, along with a PDCR from CCS, New Delhi. He has authored 8 books, contributed 22 book chapters, and published 55 research papers in reputed WOS/Scopus/UGC-CARE-listed journals. His expertise spans polymer science, novel drug delivery systems, product development, and intellectual property rights, with one granted international patent, seven published national patents, and one copyright. A certified Scientific and Medical Writer and Systematic Literature Reviewer, Dr. Suryawanshi is Co-Founder of AllWell Nutritech LLP and has managed projects worth 50 lakh at Cerelia Nutritech Pvt. Ltd. and IIT Delhi, while also securing research grants over 1.2 lakh from Gujarat government agencies. Recognized with the Young Scientist and Best Researcher Awards, he continues to contribute significantly to pharmaceutical sciences with an H-index of 7 and a strong focus on innovation, mentoring, and entrepreneurship.

Weitere Titel von Md. (Hrsg.) Faiyazuddin

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten